Neuromedin B Induces Acute Itch in Mice via the Activation of Peripheral Sensory Neurons.
Animals
Calcium
/ metabolism
Cell Degranulation
Cells, Cultured
Dermatitis, Allergic Contact
/ etiology
Female
Ganglia, Spinal
/ cytology
Gene Expression
Indoles
/ pharmacology
Injections, Intradermal
Macaca mulatta
Male
Mast Cells
/ metabolism
Mice
Neurokinin B
/ administration & dosage
Pruritus
/ chemically induced
Pyridines
/ pharmacology
RNA, Messenger
/ metabolism
Receptors, Bombesin
/ antagonists & inhibitors
Sensory Receptor Cells
/ physiology
Single-Cell Analysis
Toluene 2,4-Diisocyanate
acute itch
allergic dermatitis
dorsal root ganglia, mast cells
neuromedin B
Journal
Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310
Informations de publication
Date de publication:
01 May 2019
01 May 2019
Historique:
pubmed:
9
2
2019
medline:
8
1
2020
entrez:
9
2
2019
Statut:
ppublish
Résumé
Neuromedin B is expressed in nociceptive and itch-sensitive dorsal root ganglia neurons, but its peripheral pruritogenic potential is not well described. The potential of neuromedin B as a pruritogen and pro-inflammatory peptide in the skin was tested in vivo in an acute model in mice and monkeys as well as an allergic dermatitis model in mice. To identify the underlying mechanisms in vitro real time PCR analysis for neuromedin B and its receptor expression in murine mast cells and dorsal root ganglia as well as functional calcium imaging in the ganglia was applied. Neuromedin B induces itch when injected intradermally, and the peripheral signal is likely transmitted through the activation of dorsal root ganglia. Thus, neuromedin B could be an interesting new therapeutic target for peripheral processing of itch at the level of sensory neurons.
Identifiants
pubmed: 30734045
doi: 10.2340/00015555-3143
pmc: PMC9083373
mid: NIHMS1803241
doi:
Substances chimiques
Indoles
0
PD 168368
0
Pyridines
0
RNA, Messenger
0
Receptors, Bombesin
0
Toluene 2,4-Diisocyanate
17X7AFZ1GH
Neurokinin B
86933-75-7
neuromedin B
87096-84-2
Calcium
SY7Q814VUP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
587-893Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR059193
Pays : United States
Références
Eur J Pharmacol. 2010 Feb 25;628(1-3):226-32
pubmed: 19917276
J Neurosci. 2014 Sep 10;34(37):12402-14
pubmed: 25209280
J Pharmacol Exp Ther. 2011 Jun;337(3):822-9
pubmed: 21421741
Dermatol Clin. 2018 Jul;36(3):175-177
pubmed: 29929590
J Biol Chem. 1991 Oct 5;266(28):18771-9
pubmed: 1655761
Vet Immunol Immunopathol. 2012 Sep 15;149(1-2):136-42
pubmed: 22749291
J Dermatol Sci. 2016 Aug;83(2):106-15
pubmed: 27155791
Curr Res Transl Med. 2016 Oct - Dec;64(4):203-206
pubmed: 27939459
Acta Derm Venereol. 2015 Jan;95(1):25-30
pubmed: 24819823
J Allergy Clin Immunol. 2017 Jul;140(1):306-309.e3
pubmed: 28131799
J Pharmacol Exp Ther. 1999 Sep;290(3):1202-11
pubmed: 10454496
J Neurosci. 2012 Jun 20;32(25):8686-95
pubmed: 22723708
J Invest Dermatol. 2014 Jun;134(6):1527-1534
pubmed: 24166134
Annu Rev Biophys. 2014;43:331-55
pubmed: 24819620
Sci Rep. 2017 Nov 13;7(1):15466
pubmed: 29133874
Curr Protoc Immunol. 2010 Nov;Chapter 7:Unit7.38
pubmed: 21053305
Cancer Lett. 2011 Dec 15;312(1):117-27
pubmed: 21908103
Pharmacol Rep. 2017 Jun;69(3):438-447
pubmed: 28315588
Immunol Rev. 2018 Mar;282(1):248-264
pubmed: 29431207
J Invest Dermatol. 2009 Oct;129(10):2351-7
pubmed: 19516261
Br J Pharmacol. 2010 Aug;160(7):1577-9
pubmed: 20649561
Pharmacol Rev. 2008 Mar;60(1):1-42
pubmed: 18055507
J Invest Dermatol. 2016 Oct;136(10):1961-1969
pubmed: 27342734
PLoS One. 2013 Jun 24;8(6):e67422
pubmed: 23826298
Peptides. 2011 Oct;32(10):2098-103
pubmed: 21933692
Acta Derm Venereol. 2010 Nov;90(6):575-81
pubmed: 21057739
J Neurophysiol. 2008 Oct;100(4):2062-9
pubmed: 18562548